A study (reported in PsyPost), Review finds statin use not linked to a decline in cognitive function, gave the all-clear on statins and damage to cognitive function. It wasn’t easy to find the original – and it ought to be grounds for journalistic malpractice when they don’t link to the original – but here it is: Statins and Cognitive Function: A Systematic Review.
Conclusion: Larger and better-designed studies are needed to draw unequivocal conclusions about the effect of statins on cognition. Published data do not suggest an adverse effect of statins on cognition; however, the strength of available evidence is limited, particularly with regard to high-dose statins.
Interesting to note the potential conflicts of interest of the authors.
Potential Conflicts of Interest: Dr. Arnold: Board membership fees: TEVA Pharmaceuticals; Grants: National Institutes of Health, Pfizer, Bristol Myers Squibb, Johnson and Johnson, Merck. Dr. Rader: Personal fees: AstraZeneca, Pfizer, Merck. Dr. deGoma: Personal fees: Aegerion; Grants: Pfizer, Amgen, Novartis, Regenerol. All other authors have no disclosures.